Skip to content

Clinical efficacy and mechanism study of electroacupuncture in improving chemotherapy related fatigue in advanced gastric cancer

Clinical efficacy and mechanism study of electroacupuncture in improving chemotherapy related fatigue in advanced gastric cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083805
Enrollment
Unknown
Registered
2024-05-04
Start date
2024-05-06
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer induced fatigue

Interventions

Control group:Basic treatment of tumors (chemotherapy and symptomatic supportive treatment)
trial group:Electroacupuncture intervention+basic tumor treatment (chemotherapy and symptomatic supportive treatment)

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed by pathology as gastric adenocarcinoma and meeting the CRF diagnostic criteria, TNM staging is stages III-IV, and TCM differentiation belongs to Qi deficiency and blood stasis syndrome; (2) Based on the pathological results and the patient's own condition, specific platinum chemotherapy regimens will be applied, and it is planned to receive at least 3 courses of chemotherapy regimens with a Piper fatigue score of = 4 points; (3) Age = 45 and = 80 years old, regardless of gender; (4) Karnofsky score (KPS) = 60 points, expected survival time greater than 3 months; (5) Clear consciousness and thinking, able to correctly understand scale evaluation, and independently complete scale filling; (6) Those who voluntarily participate in this experiment and sign an informed consent form with good compliance.

Exclusion criteria

Exclusion criteria: (1) At the time of enrollment, other cancers or more severe primary diseases or bleeding tendencies of the heart, brain, liver, kidney, endocrine, blood or neuropsychiatric systems were present; (2) Patients with major infectious diseases such as AIDS, hepatitis B, hepatitis C and syphilis; (3) Patients who have received Chinese medicine, acupuncture and moxibustion and other relevant treatments or participated in clinical trials of other drugs 4 weeks before enrollment; (4) Patients with acupuncture and moxibustion allergy or psychological panic cannot cooperate with the treatment; (5) Alcohol or smoking addicts; (6) Pregnant or lactating women. If any of the above conditions are met, it will be excluded.

Design outcomes

Primary

MeasureTime frame
The Revised Piper Fatigue Scale-Chinese Version, RPFS-CV;Tumor markers:CEA,CA125,CA19-9;

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptom Score for Gastric Cancer;Cancer Quality of Life Core Questionnaire,QLQ-C30;Karnofsky;Athens Insomnia Scale,AIS;Hospital Anxiety and Depression Scales, HADS;nutritional indicator:ALB,PA,WBC,RBC,PLT,HB,;Inflammation indicators:CRP,IL-6;Thromboelastography;

Countries

China

Contacts

Public ContactLi Jing

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine

LIJINGacu@126.com+86 189 3056 8565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026